Resverlogix Corp. (RVXCF)

[growacet]

One of the biggest risks here is lack of finance....

I still think the single biggest risk is that of trial failure...but without the do re mi to get to the finish line Apabetalone can't achieve either success or failure.

I've done a fair bit of reading on success rates for drug trials and it seems the biggest drop off is in ph II with only something like 35% or so of drugs advancing to phase III. Then success in phase III is something close to 60% but those numbers are dragged down by cancer drugs which apparently have a much higher failure rate. Get to an NDA and the numbers I'm seeing suggest 90% approval.

Interestingly RVXCF traded higher at the opening while RVX went down....

I think we're going to be seeing lots more news in the coming weeks.